Atlas Trials

The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children With Severe Epilepsy

Clinical trial NCT02815540 · TERMINATED

Trial details

NCT number
NCT02815540
Sponsor
Gillette Children's Specialty Healthcare
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Lennox-Gastaut SyndromeDravet Syndrome
Start date
2017-02-16
Primary completion
2018-12-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.